Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05392621 · ClinicalTrials.gov registry record · NA

Stress Management in College Students

A NA study, sponsored by Wake Forest University.

Completed
Registry status
NA
Development phase
46
Enrollment target

NCT05392621: Completed NA study, sponsored by Wake Forest University.

NCT05392621 is a NA study that has completed, run by Wake Forest University. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05392621, a NA study, has completed, sponsored by Wake Forest University.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target

Study Summary

Stress is defined as a response to one's evaluation of physical, emotional, or environmental challenges or demands. While the experience of stress is common, chronic exposure to high levels of stress is associated with a host of negative interrelated psychological, physiological, and behavioral outcomes. Mental health problems such as anxiety and depression have a high correlation with stress. In addition, chronic diseases such as cardiovascular disease are also thought to be related to stress. For instance, research shows that stress increases blood lipids by changing cholesterol levels eventually leading to arterial thrombosis and stroke. While stress affects individuals across their lifespan, college students face a unique combination of academic and life challenges that exacerbate their experience of stress, making them highly susceptible to high levels of stress. Additionally, technological advances such as social media can be a source of chronic stress for many. As exposure to high levels of persistent stress is likely to predispose young adults to a lifetime of poor health and unhealthy behaviors, this is especially imperative in finding low impact and attainable methods of stress management for this population. Although a significant body of literature has addressed stress reduction techniques, most studies to date focus on intervention effects that accumulate over months of exposure, with many stress management programs lasting at minimum of 8 weeks. Previous research has found that interventions employing yoga, progressive muscle relaxation (PMR), and deep breathing exercise (DBE) significantly reduce stress levels. The relationship between yoga and stress reduction has been especially consistent across studies. It has been suggested that mindfulness may be the active agent in such programs. Intriguingly, Fountain et al., (2019) found a single 20-minute yoga session significantly decreased stress levels in college students. This raises the question of wh

Primary Outcome

Number consented/number contacted

Interventions

  • BEHAVIORAL Progressive Muscle Relaxation
  • BEHAVIORAL Yoga
  • BEHAVIORAL Deep Breathing
  • BEHAVIORAL Quiet sitting

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2022-06-02
Est. Completion 2023-03-31
Phase NA
Wake Forest University

100 total trials

What the finished NCT05392621 record still lists

NCT05392621 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 4 interventions - of which Progressive Muscle Relaxation is the first listed.

NCT05392621 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05392621 about?

NCT05392621 is a clinical study titled "Stress Management in College Students". Stress is defined as a response to one's evaluation of physical, emotional, or environmental challenges or demands. While the experience of stress is common, chronic exposure to high levels of stress is associated with a host of negative interrelated psychological, physiological, and behavioral outc...

What is the current status of trial NCT05392621?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2022-06-02. Estimated completion is 2023-03-31.

What interventions are being tested in trial NCT05392621?

The interventions under investigation include: Progressive Muscle Relaxation (BEHAVIORAL), Yoga (BEHAVIORAL), Deep Breathing (BEHAVIORAL), Quiet sitting (BEHAVIORAL).

Who is sponsoring clinical trial NCT05392621?

This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05392621's enrollment target sits among peer trials

46 1402nd of 2000 higher than 590 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05392621, the US trial registry maintained by the National Library of Medicine. NCT05392621 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.